# Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents

> **NCT05061030** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Uppsala University Hospital** · enrollment: 66 (estimated)

## Conditions studied

- Type1diabetes

## Interventions

- **BIOLOGICAL:** the ATMP Protrans

## Key facts

- **NCT ID:** NCT05061030
- **Lead sponsor:** Uppsala University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-14
- **Primary completion:** 2028-09
- **Final completion:** 2028-12
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05061030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05061030, "Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05061030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*